While not all PCOS patients have diabetes, the insulin-sensitizing effects apply across the insulin resistance spectrum
Last reviewed: June 29, 2026 Last updated: June 29, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
"Development and characterisation of a novel glucagon like peptide-1 receptor antibody"
If you have severe obesity, have plateaued on semaglutide or tirzepatide, or have overlapping metabolic conditions like fatty liver disease, retatrutide is the stronger intervention
Is Ivy RX available across all US states
With GLP-1 medications, the body loses fat rapidly, particularly in the face